Clozapine plasma level toxicity induced by a pharmacokinetic interaction with bupropion: A case report
Introduction Clozapine is the gold-standard antipsychotic treatment for patients with treatment-resistant schizophrenia. Prescribers must be vigilant in ensuring that all risk evaluation mitigation strategies requirements and routine cardiac and metabolic monitoring are maintained. Clozapine therape...
Saved in:
| Main Authors: | Kelly N. Gable, PharmD, BCPP, Jaron Asher, MD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Association of Psychiatric Pharmacists
2025-06-01
|
| Series: | Mental Health Clinician |
| Subjects: | |
| Online Access: | https://theijpt.org/doi/pdf/10.9740/mhc.2025.06.187 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Managing ciprofloxacin-clozapine interaction with immunoassay-based monitoring: A case report
by: Kristin Waters, PharmD, BCPS, BCPP, et al.
Published: (2025-06-01) -
Prediction of drug-drug interactions in clozapine combination therapy based on physiologically based pharmacokinetic model
by: MOU Fan, et al.
Published: (2024-11-01) -
Clozapine: Mechanisms of Toxicity and Side Effects
by: A. S. Babkina, et al.
Published: (2018-05-01) -
Clozapine and tuberculosis treatment: a case report and literature review
by: Neel Swamy, et al.
Published: (2025-07-01) -
Clozapine treatment of a Japanese patient during pregnancy: Effect on fetal heart rate
by: Shunya Aoki, et al.
Published: (2024-12-01)